Mold Antigen Liquid
NDC Package 81825-0002-1
Package Information
Mold Antigen (alternaria alternata, aspergillus fumigatus, aspergillus niger, boletus sat, botrytis cinerea, cladosporium metanigrum, fusarium oxysporum, helminthosporium, mucor muecedo, pullularia pullulans, rhizopus nigricans, ustilago maydis, arsenicum alb, candida alb, carbo an, lachesis, lycopodium, merc solub, nitricum ac, phosphorus, pulsatilla, sepia, silicea, thuja occ) liquids is uSES: Temporarily relieves symptoms associated with allergies from mold.**. This formulation utilizes a liquid delivery system. Marketed by Zorex International, this product is identified by NDC 81825-0002.
Identification & Billing
Clinical Specifications
- ALTERNARIA ALTERNATA 200 [hp_X]/mL
- ARSENIC TRIOXIDE 30 [hp_C]/mL
- ASPERGILLUS FUMIGATUS 200 [hp_X]/mL
- ASPERGILLUS NIGER VAR. NIGER 200 [hp_X]/mL
- AUREOBASIDIUM PULLULANS VAR. PULLUTANS 200 [hp_X]/mL
- BOLETUS SATANAS FRUITING BODY 200 [hp_X]/mL
- BOTRYTIS CINEREA 200 [hp_X]/mL
- CANDIDA ALBICANS 30 [hp_C]/mL
- CARBO ANIMALIS 30 [hp_C]/mL
- COCHLIOBOLUS SATIVUS 200 [hp_X]/mL
- FUSARIUM OXYSPORUM 200 [hp_X]/mL
- LACHESIS MUTA VENOM 30 [hp_C]/mL
- LYCOPODIUM CLAVATUM SPORE 30 [hp_C]/mL
- MERCURIUS SOLUBILIS 30 [hp_C]/mL
- NITRIC ACID 30 [hp_C]/mL
- PHOSPHORUS 30 [hp_C]/mL
- PULSATILLA VULGARIS WHOLE 30 [hp_C]/mL
- RHIZOPUS STOLONIFER 200 [hp_X]/mL
- SEPIA OFFICINALIS JUICE 30 [hp_C]/mL
- SILICON DIOXIDE 30 [hp_C]/mL
- THUJA OCCIDENTALIS LEAFY TWIG 30 [hp_C]/mL
- USTILAGO MAYDIS 200 [hp_X]/mL
- Allergens - [CS]
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Fungal Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Fungal Allergenic Extract - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 81825 - Zorex International
- 81825-0002 - Mold Antigen
- 81825-0002-1 - 30 mL in 1 BOTTLE, DROPPER
- 81825-0002 - Mold Antigen
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 81825-0002-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Mold Antigen, a human over the counter drug labeled by Zorex International. This liquid is formulated for oral use and contains alternaria alternata; arsenic trioxide; aspergillus fumigatus; aspergillus niger var. niger; aureobasidium pullulans var. pullutans; boletus satanas fruiting body; botrytis cinerea; candida albicans; carbo animalis; cochliobolus sativus; fusarium oxysporum; lachesis muta venom; lycopodium clavatum spore; mercurius solubilis; nitric acid; phosphorus; pulsatilla vulgaris whole; rhizopus stolonifer; sepia officinalis juice; silicon dioxide; thuja occidentalis leafy twig; ustilago maydis as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Zorex International on December 01, 2021. The current certification is valid through December 31, 2026.
How is this Zorex International product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 81825000201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.